Vident Advisory’s Mesoblast MESO Stock Holding History

Vident Advisory’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,796	Closed	-$26.6K	–	1360
2023 Q3	$26.6K	Buy	+10,796	New	+$51.6K	﹤0.01%	1242

Other funds holding MESO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LCM

Lazari Capital Management Woodland Hills, California $287M AUM 28.24% 1-Year Est. Return

SXL

Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Vident Advisory's MESO Position: Q4 2023 in Review

Vident Advisory sold out of Mesoblast (MESO) in Q4 2023, closing a stake of 10,796 shares — an estimated $26.6K sold.

Vident Advisory first reported a position in MESO in Q3 2023 and held it in 1 quarter. The position peaked at $26.6K in Q3 2023. 31 funds tracked by Wall St. Rank hold MESO as of Q4 2023.

Vident Advisory reported no remaining Mesoblast position as of Q4 2023 after selling out during the quarter.
Vident Advisory sold 10,796 Mesoblast shares in Q4 2023, an estimated $26.6K.
Vident Advisory first reported a position in Mesoblast in Q3 2023 and held it in 1 quarter.
Vident Advisory's Mesoblast position peaked at $26.6K in Q3 2023.
31 funds tracked by Wall St. Rank held Mesoblast as of Q4 2023.

Based on Vident Advisory's 13F filing for Q4 2023, filed 14 Feb 2024.